The Future of Pathogen Reduction Technology

In August of 2018, the FDA did basically tweak there and revise their recommendation. So, what they said is that during low risk times or periods, flood centers can do the testing in a mini pool using a license test. But if there was any evidence of local mosquito-borne Zika transmission in a blood center's collection area, at that point they had to convert to individual NAT testing which has more sensitivity. Right now, all blood centers, we're testing in mini pools and we've not had to trigger on to the individual nucleic acid testing for some time. The biggest game changer that I see that can significantly decrease the risk of infectious diseases, especially from emerging pathogens is pathogen